Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Davutamig (REGN-5093) is a humanized IgG4-kappa, anti-MET monoclonal antibody that binds to two distinct, nonoverlapping epitopes on the MET receptor. It functions as an antineoplastic agent [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | Davutamig (REGN-5093) is a humanized IgG4-kappa, anti-MET monoclonal antibody that binds to two distinct, nonoverlapping epitopes on the MET receptor. It functions as an antineoplastic agent [1]. |
Synonyms | REGN-5093 |
Molecular Weight | N/A |
CAS No. | 2648058-48-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Davutamig 2648058-48-2 Tyrosine Kinase/Adaptors c-Met/HGFR REGN-5093 inhibitor inhibit